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Introduction. Clostridium difficile (CD) is the most common 
cause of health-care-associated infectious diarrhea with increas-
ing incidence and severity in recent years. The main cause of 
hospital’s acquired cross infections can be attributed to incorrect 
hand hygiene. We described the epidemiology of CD infection 
(CDI) in a teaching hospital in Southern Italy during a two years 
surveillance period and evaluated the health-care workers com-
pliance to hand hygiene.
Methods. CDI Incidence rates were calculated as the number of 
patients with positive C. difficile toxin assay per 10,000 patient-
days. Compliance with hand hygiene was the ratio of the number 
of performed actions to the number of opportunities observed. 
Approximately 400 Hand Hygiene (HH) opportunities/year /ward 
were observed. We finally checked out if any correlation could be 
found.
Results. From January 2015 to December 2016 a total number of 
854 CD determinations were performed in patients with clinical 
symptoms of diarrhea. The search for toxins A and B was positive 
in 175 cases (21,2%), confirming the diagnosis of CDI. Compli-
ance to hand hygiene was significantly inversely associated with 
the number of CDIs: the lower the compliance of  health-care 
workers with hand hygiene the higher was the number of cases of 
CDIs (p = 0.003).
Conclusions. According to our results proper handwashing of 
health-care workers appears to be a key intervention in interrupt-
ing CD cross infections regardless of age and type of department 
in which the patient is admitted.
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Summary
Introduction
Clostridium difficile (CD) is the most common cause of 
health-care associated infectious diarrhea. 
It has been estimated that CD infection (CDI) is re-
sponsible for over 500,000 enteric infections per year 
in the United States, the majority of which are hospital 
acquired [1-3]. Both the incidence and severity of CDI 
have increased in recent years [4]. At least 7–17% of 
adult hospitalized patients are colonized by CD, with 
higher rates observed in elderly long-term patients [5]. 
Recurrence occurs in 25-33% of patients with primary 
CDI treated with metronidazole or oral vancomycin. 
CDI includes a spectrum of clinical features ranging 
from asymptomatic individuals to CD-associated diar-
rhea (CDAD) and pseudomembranous colitis, which can 
lead to fulminant, relapsing, and/or fatal colitis  [6,  7]. 
Risk factors for CDI are 65+ years of age, female gender, 
previous or concomitant antibiotic exposure, prolonged 
stay in a health-care facility, immunodeficiency, renal 
impairment, previous antibiotic exposure and chemo-
therapy [8-12]. 
Hand hygiene has also shown to be the most important 
risk factor in hospital’s acquired infections [13].
As reported by another study, natural history of cas-
es may explain differences in epidemiology of CDIs 
among hospitals and should be considered to iden-
tify the most effective measures to reduce their in-
cidence [14]. Therefore, our study had the following 
objectives: describe the epidemiology of CDI in a 
teaching hospital in Southern Italy during two-year-
surveillance period and evaluate the percentage of 
adherence to official hand washing procedures, by 
hospital care personnel, to determine whether any 
correlation does exist. 
Methods
This study was conducted between January 1, 2015, and 
December 31, 2016, in Catania University Hospital “G. 
Rodolico”, a reference teaching and research hospital in 
Sicily, Italy. 
Study endpoints
The primary endpoint was the overall incidence of 
CDI/10,000 patients days over two years period. Sec-
ondary endpoint were: (i) incidence of CDI/10,000 pa-
tient days stratified per specialty area, (ii) proportion of 
children’s cases, (iii) percentage of adherence to hand-
washing procedure.
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CD infection
For the definition of CDI we have used the following 
criteria proposed by the European Centre for Disease 
Prevention and Control (ECDC): diarrheal stool or toxic 
megacolon and positive laboratory assay for CD toxin A 
and/or toxin B in stools [15]. We only considered diag-
noses of CDI confirmed by laboratory tests performed 
in the Central Laboratory. We did not consider clinical 
criteria and pseudomembranous colitis revealed by en-
doscopy or on a specimen obtained during endoscopy. 
We have separated the CDI diagnoses observed in out-
patient settings.
A case of hospital-acquired CDI (HA-CDI) was defined 
according to the criteria of the Clostridium difficile Study 
Group of the European Society of Clinical Microbiol-
ogy and Infectious Diseases as follows: any patient who 
developed symptoms of diarrhea at least 48 hours after 
admission to the hospital (HA-CDI case with hospital 
onset); any patient who was admitted with symptoms of 
diarrhea at the hospital with an onset of symptoms in 
the community within 4 weeks following discharge from 
the hospital (HA-CDI case with community onset) and 
patients who had stool samples positive for CD toxin A 
or B or positive for toxin-producing CD [16].
All stools samples were tested with a two-step algorithm 
for detecting toxigenic CD: an enzyme immunoassay 
for glutamate dehydrogenase (GDH) antigen and sub-
sequent enzyme immunoassay for CD toxins A and B. 
The assay principle combines a two-step enzyme immu-
noassay sandwich method with final fluorescent detec-
tion (ELFA). Laboratory data were collected from the 
Central Information System.
Epidemiological characteristics of patients (age and 
gender) and clinical history were collected from the hos-
pital’s digital archives of the patients and then verified in 
clinical charts. Clinical history was defined as diagnosis 
according to International Classification Disease (ICD) 
9th version, comorbidities, previous hospitalization and 
length of hospital stay.
Positive cases per GDH were stratified by year and by 
ward, namely (i) general medicine, (ii) surgery (iii), pae-
diatrics and (iv) intensive care. The incidence of CDI was 
expressed as the number of CDI cases /10,000 patient 
days for both overall incidence and stratified per spe-
cialty area. Admissions and length of hospital days were 
extrapolated from the hospital’s admission archives.
Hand washing procedure
We assessed compliance to the hand washing proce-
dures described in World Health Organization (WHO) 
guidelines [17], while delivering routine care. The WHO 
guidelines indicate 5 moments of hand’s hygiene in 
health-care: before touching a patient or before having 
contact with an object belonging to the healthcare area; 
before a clean/aseptic procedure; after body fluid expo-
sure; after touching a patient and after touching patient 
surroundings.
We used WHO Observation Form to directly assess ad-
herence to the protocol in any of the above mentioned 
five moments by direct visual observation of health-care 
workers attitude on at least 200 opportunities every six 
months. Where several indications coincided in a single 
opportunity, as WHO required, each indication was re-
corded and the action was then multiplied by the num-
ber of indications. The observation data were collected 
anonymously by the hospital infection control group 
every six months, in different wards.
According to the WHO manual, we considered appropri-
ate hand washing with water and soap or hand hygiene 
with alcoholic gel with the exception of dirty or con-
taminated hands with patients affected by CDI.
Data were imputed in a local database purposely devel-
oped.
Compliance was calculated by adding the results of each 
session and dividing the total number of positive actions 
by the total number of opportunities.
Results of compliance with hand hygiene through two 
years period of observation (2015 and 2016) are report-
ed.
Statistical methods 
To identify the risk (probability) of infection in the pa-
tients, we used incidence rate. Incidence rates were cal-
culated as the number of patients with positive CD toxin 
assay per 10,000 patient-days and were stratified per 
specialty and per age.
We calculated the compliance rate as the adherence to 
the procedure in the wards over the total number of op-
portunities observed in each ward. 
We also calculated the overall compliance rate of the dif-
ferent four medical areas. We compared the incidence 
rate of CDI cases per area with its compliance rate to 
hand washing procedure.
We performed a covariance analysis in order to see if 
any difference in mean compliance could explain rela-
tive differences in incidence rates.
The degree of linear correlation between the incidence 
of CDI cases observed and the compliance rates was 
measured by means Pearson’s statistic.
The significance level was set to p < 0.05.
Results
CDI rates
From January 2015 to December 2016, a total of 854 CD 
determinations were performed in patients with clinical 
symptoms of diarrhea, who were either hospitalized or 
outpatients (Fig. 1). In 215 samples, glutamate dehydro-
genase antigen (GDH) was positive. In these patients, 
the test for toxin A and B was positive in 175 cases 
(21.2%), confirming the diagnosis of CDI.
In Table I the number of stool sampled, the percentage 
of positive exams, the number of inpatient and outpa-
tient cases observed, the incidence of CDI (cases/10,000 
patients days) are described. In 2015, 57 positive exams 
were detected for CD. Fifty cases came from patients 
hospitalized in 10 wards and seven from outpatients.
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During 2016, we had 118 positive CD tests 106 of which 
were diagnosed in 11 wards and twelve from outpa-
tients. As can be seen in Table I, the number of CDI 
cases increased in 2016 despite fewer total admissions. 
In 2016, there was a 14% increase in the number of tests 
performed relative to the previous year. The overall inci-
dence was 0.1/10000 patient-days in 2015, and this fig-
ure increased to 0.23/10000 patient-days in 2016. 
The number of cases in different departments is given in 
Table II. CDI cases were most frequently diagnosed in 
general medicine wards. The number of hospital admis-
sions refers only to units in which cases were detected.
In Table III we report the number of cases of total CDI 
divided by age groups. Approximately 28% of all cases 
involved children aged 0-17 years. Most of these patients 
exhibited surgical abnormalities of the gastrointestinal 
tract (25.6%). Only one paediatric patient was affected 
by cystic fibrosis. Approximately 35% of cases were 
confirmed in patients over 65 years of age. The other 
cases were distributed in the middle age group.
Age, sex, length of stays and outcome of cases are de-
scribed in Table IV. Since we sampled approximately the 
same number of males and female we didn’t find any 
difference between sex as others described [18]. It is 
particularly relevant the larger length of stay (LOS) in 
2016, with an extreme case of 234 days, to which can 
be probably attributed a greater chance of CDI cases. 
The mean hospital length of stay of CDI was 27 days 
in 2015 and 27.6 days in 2016. Two patients relapsed in 
2015 and four relapsed in 2016. The patients primarily 
treated with a cycle of metronidazole were subsequently 
treated with oral vancomycin. No fidaxomicin treatment 
was necessary.
Fig. 1. Study flow chart. Description of the path from the stool cultures to the definition of the number of Clostridium difficile infection 
cases in the different years.
Tab. I. Stool samples tested (numbers and incidence rates) and Clostridium difficile infection (CDI) cases (numbers and incidence rates) per 
10000 patients-days per year.
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2015 13056 6383 19439 770 57 7.4 50 0.1 7 0.03
2016 12640 5688 18328 825 118 14.3 106 0.23 12 0.05
LEGEND 
CD (Clostridium difficile)
CDI (Clostridium difficile infection)
CDAD (CD-associated diarrhea)
ECDC (European Centre for Disease Pre-
vention and Control)
HA-CDI (Hospital acquired-CDI)
GDH (glutamate dehydrogenase)
ELFA (Enzyme Linked Fluorescent Assay)
ICD (International Classification Disease)
WHO (World Health Organization)
HH (hand hygiene)
CF (cystic fibrosis)
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Tab. II. Hospital admissions and incidence of Clostridium difficile infections (CDI) in the different wards per areas during the study period (2015-
2016).
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General medicine area 843 36 4.27 1.16 918 55 5.99 1.64
Surgical area 1705 4 0.23 0.06 1443 10 0.69 0.189
Paediatric area 1141 7 0.61 0.16 1866 38 0.53 0.55
Intensive care 207 3 1.44 0.39 219 3 1.36 0.37
Tab. III. Clostridium difficile Infections (CDI) stratified by area and by age groups.
    CDI n 0-17 years 18 - 65 years > 65 years
OVERALL  156    
General medicine area
2015 35   18 17
2016 55   26 29
Surgical area
2015 4   3 1
2016 10   3 7
Paediatric area
2015 8 7 1  
2016 38 34 4  
Intensive care unit
2015 3 2 1  
2016 3 1 2  
44 (28%) 58 (37%) 54 (35%)
Tab. IV. Age, sex, length of stays and outcomes of Clostridium difficile infections (CDI). 
  2015 2016
Sex: - Male 29 (50.5%) 55 (47.4%)
 - Female 28 (49.5%) 61 (52.6)
Age (years) - Mean 48.9 41.6
 - Median 56 48
 - Range 0-91 0-96
Length of stays (days) - Mean 27 27.6
 - Median 22 16
 - Range 3-144 2-234
Recurrence/relapse 2 (3.6%) 4 (3.4%)
Death 7 2
 - Age 0-17 0 1
 - Age 18-65 1 0
 - Age > 65 6 1
 - Ward
1 ICU 1 ICU
6 General Medicine area 1 Paediatric Area
Tab. V. Number of CDI, Incidence rates and mean Hand Hygiene Compliance rates stratified by area and by period.
  Areas CDI cases
Incidence/10000 
patient-days
Number of 
opportunities
Hand hygiene 
compliance (%)
20
15
General Medicine area 2015 35 1.13 848 47
Surgical area 2015 4 0.06 840 72
Paediatric area 2015 8 0.19 828 78
Intensive care unit 2015 3 0.39 492 58
20
16
General Medicine area 2016 55 1.64 823 44
Surgical area 2016 10 0.189 840 65
Paediatric area 2016 38 0.55 830 65
Intensive care unit 2016 3 0.37 457 60
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The C. difficile International Classification of Diseases, 
ninth version, clinical modification (ICD-9-CM) code 
008.45 was assigned as the principal discharge diagnosis 
only in 9 cases.
The most prevalent comorbidities in older patients were 
cardiovascular (32.4%) and gastrointestinal (20.6%) dis-
eases.
Hand hygiene
Standardized documented activities requiring hand hy-
giene (HH), according to the WHO protocol, were veri-
fied. Approximately 400 HH opportunities/year/ward 
were observed. In total 5940 circumstances requiring 
hand hygiene were observed over two years. We calcu-
lated the mean compliance rate in each area; we directly 
observed two wards in the general medicine, surgical 
and paediatric areas and in the intensive care unit, twice 
per year. In Table V, we report the results of the percent-
age of adherence to the application of WHO guidelines 
on hand hygiene as observed during 2015 and 2016. 
The survey analysis showed high variability among the 
wards, ranging from the highest value reached in paedi-
atric units in 2015 (78%) to the lowest value observed in 
general medicine wards in 2016 (44%).
Results from covariance analysis performed on data 
showed no significant difference in mean incidence rate 
between 2015 and 2016 (p = 0,15) while common sig-
nificant linear correlation was conversely found between 
adherence to hand washing procedure and incidence 
rates within medical areas. Negative linear correlation 
coefficient was -0.8911 (p  =  0.003) showing that the 
poorer adherence to the procedure the greater the inci-
dence rate (Fig. 2).
Discussion
CD is the most important cause of healthcare-associated 
diarrhea in both normal and immunocompromised hosts 
and is increasingly important as a community patho-
gen  [19]. It has been found to be the major aetiologic 
agent of antibiotic-associated pseudomembranous coli-
tis, a clinically defined syndrome associated with a re-
cent history of antibiotic use in which pseudomembra-
nous nodules or plaques can be found in the distal and 
sigmoid colon and rectum. If unrecognized or untreated, 
this disease can be fatal.
Our increase in CDI cases is consistent with that recently 
reported in the literature [20, 21]. We argue that since 
tests were performed only in patients with gastrointes-
tinal symptoms of diarrhea, the greater number of tests 
performed in 2016 relates to an increased amount of 
positive cases founded.
As shown in Table III, patients hospitalized in internal 
medicine wards were at higher risk for CDI and CDI 
incidence increased with age over 65, similarly reported 
in other studies [14, 20, 21]. Older patients have more 
comorbidities and are hospitalized more frequently than 
Fig. 2. Linear correlation between Clostridium difficile incidence rates and Hand Hygiene compliance rates.
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younger patients [22]. In our study, the most prevalent 
comorbidities were cardiovascular (32.4%) and gastro-
intestinal (20.6%) conditions. 
Interestingly we found a high incidence of positive cases 
(28%) in patients under 18 years old. Our 44 diagnoses 
referred to children that had diarrhea and diseases in-
volving malformations of the digestive system. CD colo-
nization of health individuals is associated with changes 
in distal gut microbial composition [23]. This phenom-
enon is much more frequent in paediatric patients, espe-
cially in infants. CDI is a relatively uncommon but costly 
complication after paediatric operative procedures [24]. 
Infants and paediatric patients with cystic fibrosis (CF) 
have shown to be asymptomatic carriers of toxigenic CD 
with reported CD colonization rates as high as 50% in 
infants and from 22 to 46% in the others [25-27]. How-
ever, despite this high rate of colonization, the occur-
rence of CDI in CF remains rare. 
The large number of cases in paediatric subjects in our 
study is probably due to the high concentration of chil-
dren with severe connatural surgical pathologies treated 
in our paediatric surgery or to children treated in our re-
gional centers for diagnosis of cystic fibrosis and for the 
treatment of oncology disease in paediatric age.
The mean LOS is roughly the same in the two years with 
a large variability from one case to another. Hospital 
LOS has a double relationship with CDI because its in-
crease is a well-known risk factor for cross-CDI and pa-
tients with CDI tend to stay in the hospital longer [28]. 
The permanence of a patient colonized by CD is a risk 
factor for nosocomial infection, which can be easily 
transmitted by the improperly washed hands of the as-
sisting staff or relatives who are unidentified dissemina-
tors of the germ itself.
As can be seen in Table I the number of positive tests in 
2016 were more than twice those positive in 2015, while 
incidence rates increased accordingly in inpatients, more 
than those occurred in outpatients. This confirm the role 
of proper hand-washing in CD cross-infections, as far 
as most health care-associated infections are preventable 
with good hand hygiene. It means cleaning hands at the 
right time and in the right way. Hand hygiene is a key in-
tervention in interrupting transmission between patients, 
health care personnel and visitors [29, 30]. 
In our hospital, we have regular monitoring and evalu-
ation quality protocol to control hand-washing hospital 
procedure. We perform hand washing following the five 
times for hand hygiene set by the WHO, as previously 
cited. 
Our results gave us knowledge of how health-care work-
ers perform hand hygiene. The data confirm the low com-
pliance to hand hygiene practices of healthcare workers: 
no department reached 80% compliance, which is the 
limit recommended by the WHO. Not surprisingly we 
found a reverse correlation between the number of CDI 
cases recorded and the percentage of adherence to hand 
washing: the lower the compliance with HH, the higher 
the number of CDI. 
Since this practice remains well below WHO recom-
mendations, continual efforts are required to reach the 
optima targeted goal to prevent HA- CDI. A better knowl-
edge of the importance of hand hygiene remains an effec-
tive health care-associated infection control intervention. 
Nevertheless, other measures for infection control must 
be reminded such as isolation of infected patients, use of 
gloves, gowns and chemical agents for environmental dis-
infection. Hydrogen peroxide vapours for terminal decon-
tamination has been proven to be effective against CD, as 
has been recently reported [31-33]. 
Finally, our analysis suffers from some limitations. 
Firstly, we considered only diagnoses of CD infection 
carried out by laboratory tests. For diagnosis, we used 
EIAs that are easy and fast to perform but with a sen-
sitivity ranging from 63% to 99%; thus, false-negative 
results could occur. Moreover, we did not consider pseu-
domembranous colitis revealed by endoscopy or on a 
specimen obtained during endoscopy. This decision may 
have resulted in missed cases.
Secondly, our study was a single centre study in a teach-
ing hospital and results may not be reproducible in dif-
ferent contexts. HH observations were carried out by 
trained staff twice a year, a greater number of observa-
tions or video recordings of the actions might lead to 
different results.
Conclusions
CD is a well-known cause of hospital-acquired infec-
tious diarrhea with prolonged hospitalizations, increas-
ing patient morbidity and healthcare costs [34, 35]. Cli-
nicians should consider a diagnosis of CDI in patients 
with severe diarrhea. Early recognition of CD coloniza-
tion may help to prevent the spread of HA-CDI and the 
risk of transmission to non-infected patients or health-
care workers.
To reduce the incidence of CDI, it is imperative to be 
aware of at-risk population, which might be different 
in general or specialized hospitals. The large number 
of cases in paediatric subjects in our study is probably 
due to the high concentration of children with severe 
connatural surgical pathologies treated in our paediatric 
surgery centre and children who were treated in our re-
gional reference centres for cystic fibrosis or oncology 
pathology.
Given the results of our survey, we propose that screen-
ing is performed in all patients admitted to the Inten-
sive Care Unit, in all immunosuppressed patients over 
65 years of age with the described comorbidities and in 
paediatric patients with gastrointestinal abnormalities or 
tumours. Screening should be performed by detecting 
GDH in stool in order to select colonized patients and 
prevent outbreaks.
Because of the difficulties associated with the isolation 
of infected patients in a single room with personal bath-
rooms, proper hand-washing remains a key intervention 
in interrupting transmission between patients, health 
care personnel and visitors.
Continuous surveillance is required to determine trends 
and verify whether more toxigenic strains have an in-
CORRELATION BETWEEN HA-CDI AND HAND HYGIENE
E151
creasing impact in the community and in a hospital set-
ting [36].
Further studies are required to verify whether the pro-
posed measures might restrict the spread of infections 
due to secondary outbreaks.
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